Análise da Atuação da Comissão de Farmácia e Terapêutica em um Hospital Universitário da Paraíba

Abstract

The Pharmacy and Therapeutics Committee aims to advise the manager and the healthcare team regarding medicines, ensuring safe and rational use. To this end, the objective was to analyze the performance of CFT in a university hospital in Paraíba. This is a descriptive and exploratory study of a retrospective nature, produced based on the annual reports prepared by the CFT in the 2022-2023 biennium. The statistical analysis consisted of determining the percentage for indicators such as scheduled and held meetings, standardized medications and destandardized medications. The study did not require approval from the Ethics Committee, as it is research involving public domain data. based on the data collected, it was found that between 2022 and 2023, the CFT carried out essential activities, such as the elaboration of Standard Operating Procedures (SOP), the review of the medicine standardization list, the production of the Pharmacotherapeutic Guide and team training assistance. In 2022, there was 100% execution of planned meetings, and a percentage of 2.44% of new items in the list of standardized medicines, while 5.7% of items were destandardized, reflecting a continuous process of evaluation and adjustment of the standardization of medications. In 2023, 0.89% of medicines were standardized and 11.21% were destandardized. In total, 39 items were evaluated, resulting in the destandardization of 25 medications due to low consumption, risk of loss and unjustifiable demand. In the end, it appears that the CFT of the hospital that served as a research field, throughout the biennium analyzed, demonstrated its importance for the rational and safe use of medicines in the institution, having even implemented significant updates to the institutional list of medicines standardized.